|
|
| Management |
 |
 |
|
| Epigenomics is managed by a team characterized by a unique mix of seasoned diagnostics industry experience, science and management expertise, and the entrepreneurial commitment to build a world leading cancer molecular diagnostics company based on DNA methylation: |
|
|
|
|
|
Geert Walther Nygaard, CEO
Geert has a distinguished career in the global Diagnostics industry. He joined Epigenomics in February 2007 from a position as Managing Director and member of the Management Board of pharmaceutical and diagnostics company Abbott GmbH & Co. KG in Wiesbaden, Germany, where he held the commercial responsibility for the Diagnostic Division. Geert has an academic background in chemical engineering and received marketing and management training at INSEAD in France. He started his career in Denmark, working for Diagnostics companies Beckman Instruments and Dako A/S in national and international positions. He joined Abbott in 1999 as the company’s Country Manager in Denmark from a position as Managing Director of Dako AG in Switzerland. He then moved on into positions with increasing responsibilities, including business development and marketing for Abbott Diagnostics in Europe.
|
|
|
|
|
Oliver Schacht, CFO, CEO Epigenomics, Inc.
Oliver holds a Diploma in European Business Administration from the European School of Business in Reutlingen and London as well as a Master's Degree and PhD from the University of Cambridge (UK). With Mercer Management Consulting between 1995 and 1998, he worked on projects in M&A, growth strategies and re-organization in pharma, biotech, and other sectors. Oliver who co-founded Epigenomics in 1998 has been with the Company as CFO since June 1999. He has been responsible as CEO of Epigenomics, Inc., Seattle since January 2006. During his tenure with Epigenomics Oliver has been responsible for three series of VC rounds, the company's IPO on the Frankfurt Stock Exchange in 2004, the merger and post merger integration with Seattle based ORCA Biosciences, as well as several PIPE placements and public rights offerings in recent years. Oliver is a co-founder of several start-up businesses and most recently he joined the supervisory board of Curetis AG, a venture backed molecular diagnostics company developing infectious disease tests on a novel integrated platform.
|
|
|
|
|
Achim Plum, Senior VP Corporate Development
Achim studied molecular genetics, cell biology and biochemistry at the University of Bonn and the University of East Anglia, Norwich/UK. He obtained his PhD in molecular genetics from the University of Bonn. Before joining Epigenomics, Achim held various positions in R&D management, project management and business development and the biotechnology and pharma industry. He first started working for Epigenomics in 2003 as a project manager and later headed the R&D of the biomarker service business. In 2006 Achim took over the responsibility for Epigenomics’ investor and public relations. In his current position as Senior Vice President Corporate Development he heads the departments Marekting & Sales, Business Development and Communications.
|
|
|
|
|
Dr. Uwe Staub, Senior VP Product Development
Uwe studied Biology at the University of Wuerzburg, Germany, and earned his Ph.D. in Biochemistry and Human Genetics. Before joining Epigenomics, Uwe worked 14 years in the IVD industry for Abbott Diagnostics, Digene and Qiagen and gained experience in Operations, Quality and Regulatory Affairs as well as Product Development. Uwe heads Epigenomics' product development departments and the study management and data support group.
|
|
|
|
|
Albert Weber, Senior VP Finance, Accounting & Controlling
Albert earned his degree in business administration at the University of Cologne. After several years in various accounting and treasury functions with large corporate players (Sony, EMI), he joined Pironet, an IT start-up. He headed their controlling team and was part of the IPO team. In 2000 he joined Epigenomics and heads the entire accounting, controlling, purchasing and general administration team.
|
|
top of the page
|
